ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,746Medicare Part D Prescriptions Filled, Including Refills

Rank: 34 out of 586

$463K Total Retail Price of All Prescriptions

Rank: 30 out of 586

345 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
40% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Utah
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 345 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

21% of this provider’s 345 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

1% of this provider’s 6,063 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Utah
HYDROCODONE-ACETAMINOPHEN 435 343 S3 1 5
SIMVASTATIN 376 302 2 1
OMEPRAZOLE 350 278 3 3
LEVOTHYROXINE SODIUM 293 250 4 2
POTASSIUM CHLORIDE 186 161 5 14
LISINOPRIL 169 149 6 4
FUROSEMIDE 166 150 7 9
LISINOPRIL-HYDROCHLOROTHIAZIDE 134 119 8 16
CITALOPRAM HBR 114 93 9 12
MELOXICAM 112 97 10 25
ZOLPIDEM TARTRATE 110 48 11 8
METFORMIN HCL 110 79 11 6
TAMSULOSIN HCL 107 105 13 27
HYDROCHLOROTHIAZIDE 107 103 13 10
SERTRALINE HCL 102 97 15 21
TRAMADOL HCL 101 59 16 15
DONEPEZIL HCL 96 96 17 40
WARFARIN SODIUM 95 81 18 13
GLIPIZIDE ER 82 78 19 121
FLUTICASONE PROPIONATE 80 55 20 28
GABAPENTIN 77 48 21 11
FLUOXETINE HCL 75 46 22 24
AMLODIPINE BESYLATE 72 66 23 7
LEVOXYL 67 47 24 70
HYDROMORPHONE HCL 67 0 S2 24 204
KLOR-CON 8 66 53 26 208
ALENDRONATE SODIUM 65 65 27 23
CRESTOR 63 47 28 42
METOPROLOL SUCCINATE 61 41 29 19
IBUPROFEN 60 40 30 43
POLYETHYLENE GLYCOL 3350 60 60 30 47
PANTOPRAZOLE SODIUM 59 49 32 68
LANTUS 59 42 32 33
ROPINIROLE HCL 56 46 34 95
METOPROLOL TARTRATE 54 51 35 26
CEPHALEXIN 54 50 35 105
OXYCODONE HCL 54 42 S2 35 32
NEXIUM 53 16 38 51
DICLOFENAC SODIUM 50 36 39 85
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 11, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.